In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hospital, Heal Thyself

Executive Summary

Some time in the next several months, the hospital group purchasing organization will undergo a level of public scrutiny that it has never experienced before. Two US senators are gearing up to hold hearings on the industry, specifically to explore the negative impact that group purchasing has had on competition among medical device and hospital supply companies. Ironically, one could argue that rather than pitting hospitals against suppliers, group purchasing could eventually prove about as bad for hospitals as it has been for some suppliers. By reducing the number of competitors in product categories, by creating the very oligopolies that small suppliers rail against, GPOs, and by extension the hospitals they serve--have boxed themselves into a corner.

You may also be interested in...



Abbott Spins Off its Hospital Products Group--and Then There Were None

Abbott's announced spin-off of its hospital supply business suggests once and for all that a key medical device model of the 1980s is now dead. At the same time, it creates an enormous company with significant resources.

Is Group Purchasing Broke?

Facing unprecedented scrutiny from major media and the US Senate, leading GPOs are beginning to revamp their policies to address concerns on the part of small suppliers that the current system unfairly excludes them. But given the animosity between the two sides, will there ever be a meeting of the minds on GPO reform?

GPOs Cry Foul Following Senate Hearings

Facing intense scrutiny from both Senate hearings and a series of articles in the New York Times, GPO executives scramble to defend their practices even as they promise to pay more attention to the issues their critics raise.

Related Content

Topics

UsernamePublicRestriction

Register

IV001746

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel